Cellpep Pharma is developing oncology and infectious disease therapeutics.

History:

Cellpep Pharma merged with Procyon BioPharma in 2006 to become Ambrilia Biopharma.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: